Tanshinone I
Ukusetyenziswa kwe-tanshinone I
I-Tanshinone I luhlobo lwe-IIA lwe-recombinant yabantu i-sPLA2 kunye ne-Rabbit Recombinant cPLA2 inhibitor ene-IC50 ye-11, ngokulandelanayo μ M kunye ne-82 μ M.
Igama likaTanshinone I
Igama lesiNgesi: tanshinone I
Isi-Chinese Alias: tanshinone I |tanshinone mna |I-1,6-dimethyl-phenanthro [1,2-b] i-furan-10,11-dione |tanshinone mna |tanshinone mna |tanshinone I
I-Bioactivity yeTanshinone I
Inkcazo:tanshinone I luhlobo IIA yabantu recombinant sPLA2 kunye noMvundla Recombinant cPLA2 inhibitor ene-IC50 ye-11 ngokulandelelanayo μ M kunye ne-82 μ M.
Iindidi ezinxulumeneyo:iindlela zokubonisa > > i-enzymes ye-metabolic /
proteases > > phospholipids
Indawo yophando > > isifo sentliziyo
Iimveliso zeNdalo > > IiQuinones
Ekujoliswe kuko:IC50: 11 μM (sPLA2), 82 μM (cPLA2) [1].
Isifundo se-In Vitro:I-tanshinone ndathintela ukubunjwa kwe-PGE2 nge-LPS eyenza i-macrophages eluhlaza (IC50 = 38 μ M) ). Xa yongezwa emva kokungeniswa okupheleleyo kwe-COX-2, i-tanshinone ndaye ndanciphisa ukuveliswa kwe-PGE2 (IC50 = 46) μ M) Inyaniso yokuba i-tanshinone inqanda i-PGE 2 imveliso ngokusebenzisa i-COX-2 yangaphambili iphakamisa kakhulu ukuba i-compound ingakwazi. inqanda ngokuthe ngqo umsebenzi we-COX-2 kunye / okanye ichaphazela umsebenzi we-PLA2. Xa i-tanshinone ndifakwe kwiifom ezimbini ezahlukeneyo ze-phospholipase A2 (PLA2), yayinqande kakhulu i-sPLA2 ngendlela yokuxhomekeka koxinzelelo (IC50 = 11) μ M) Nangona iphantsi kwayo. amandla, tanshinone Ndikwanqande cPLA2 (IC50 = 82) μ M)[1]
KwiSifundo seVivo:tanshinone Ndabonisa umsebenzi wokuchasana nokudumba kwi-carrageenan eyenza i-paw edema kunye ne-adjuvant induced arthritis kwiigundane.Ukuze kusekwe umsebenzi wokuchasana nokudumba kwe-tanshinone I, iimodeli zezilwanyana zakudala zokuvuvukala okubukhali kunye nokungapheliyo [i-rat carrageenan (CGN) - i-paw edema eyenziwe kunye ne-rat adjuvant induced arthritis (AIA)] yasetyenziswa.Xa i-tanshinone yomlomo I, ibonise umsebenzi ochasene nokuvuvukala kwi-CGN eyenza i-paw edema (i-47% inhibition kwi-160 mg / kg), ngelixa i-IC50 ye-indomethacin yayingu-7.1 mg / kg.Kwi-AIA, i-tanshinone ndinike i-27% inhibition yokuvuvukala kwesibini ngosuku lwe-18 kwi-dose yomlomo ye-50 mg / kg / ngosuku, ngelixa i-prednisolone (5 mg / kg / ngosuku) ibonise ukuvinjelwa okusebenzayo (65%) [1]
Uvavanyo lukaKinase:njengomthombo we-PLA2, i-sPLA2 ye-recombinant (uhlobo lwe-IIA) yahlanjululwa kwiiseli ze-CHO ezigqitywe nge-PLA2 gene, kunye ne-rabbit recombinant platelet cPLA2 yafunyanwa ngokubonakaliswa kwayo kwi-baculovirus.Standard reaction umxube (200) μ 50) Yayiqulathe 100 mm Tris HCl buffer (pH 9.0), 6 mM CaCl2 kunye 20 nmol 1-acyl - [1-14C] - arachidonyl Sn glycerol phosphate ethanolamine (2000 CPM / nmol).Okanye kwakungekho tanshinone I. impendulo yaqalwa ngokudibanisa 50NG purified sPLA2 okanye cPLA2.Emva kwemizuzu engama-20 kwi-37 ℃, iiasidi ezinamafutha asimahla avelisiweyo ahlalutywa.Ngaphantsi kwezi meko eziqhelekileyo, malunga ne-10% ye-fatty acids yamahhala ikhutshwe kwi-substrate ye-phospholipid eyongezelelweyo kumxube wokuphendula ngaphandle kwe-tanshinone I [1].
Uvavanyo lweSeli:iiseli ze-264.7 ezikrwada zakhuliswa kunye ne-DMEM eyongezwa nge-10% ye-FBS kunye ne-1% ye-antibiotics kwi-37 ℃ phantsi kwe-5% CO2.Ngamafutshane, iiseli zahlwayelwa kwiiplate ze-96 kakuhle (2) × 10 (iiseli ezi-5 / kakuhle).Ngaphandle kokuba kuboniswe ngenye indlela, i-LPS (1ug / ml) kunye ne-tanshinone ndongezwa kwaye ndifakwe kwiiyure ze-24.Ugxininiso lwe-PGE2 oluphakathi lulinganiswe kusetyenziswa ikhithi ye-EIA ye-PGE2.Ukuze unqume umphumo we-tanshinone I kwi-PGE 2 yokuveliswa emva kokungeniswa kwe-COX-2, iiseli zixutywe kunye ne-LPS (1 μ G / ml) kwiiyure ze-24 kwaye zihlanjwe kakuhle.Emva koko, i-tanshinone ndongezwa ngaphandle kwe-LPS kwaye iiseli zakhuliswa ezinye iiyure ezingama-24.Ugxininiso lwe-PGE2 lulinganiswa ukusuka phakathi.Uvavanyo lwe-MTT lwalusetyenziselwa ukuvavanya i-cytotoxicity ye-tanshinone I kwiiseli eziluhlaza.I-Tanshinone I kwi-100 μ M ayizange ibonise nayiphi na i-cytotoxicity [1].
Uvavanyo lwezilwanyana:ukwenzela ukuvavanya umsebenzi we-inhibitory we-tanshinone I kwiimodeli zezilwanyana ezivuthayo kunye ezingapheliyo, i-rat carrageenan (CGN) - i-paw edema eyenziwe nge-paw kunye ne-adjuvant induced arthritis (AIA) isetyenziswe.Ngamafutshane, i-1% ye-CGN echithwe kwi-saline yamahhala ye-pyrogen (0.05 ml) ifakwe kwi-paw yangemva yangemva yeegundane zokuvavanya i-paw edema.Emva kweeyure ze-5, ukudumba kweenzipho eziphathwayo kulinganiswa kusetyenziswa i-plethysmograph.I-Tanshinone ndachithwa kwi-0.5% ye-CMC ilawulwa ngomlomo ngeyure ye-1 ngaphambi kwe-CGN injection.Kuvavanyo lwe-AIA, ukudumba kwe-arthritic kwenziwa ngokutofa iMycobacterium lactis (0.6ml / ibuzi) inyibilikiswe kwioyile yamaminerali kwimpuku yangasemva yasekunene.ITanshinone ndandiyinikwa ngomlomo yonke imihla.Ukwandiswa kweenzipho ezinyangwayo nezinganyangwanga kwalinganiswa kusetyenziswa iplethysmograph.
IiReferensi:[1] UKim SY, et al.Iziphumo ze-Tanshinone I zahlukanisiwe kwi-Salvia miltiorrhiza bunge kwi-arachidonic acid metabolism kunye neempendulo ezivuthayo ezivuthayo.Phytother Res.2002 Nov;16(7):616-20.
IiPropati zoMzi kunye nezeMichiza zeTanshinone I
Ubuninzi: 1.3 ± 0.1 g / cm3
Indawo yokubilisa: 498.0 ± 24.0 ° C kwi-760 mmHg
Indawo yokunyibilika: 233-234 º C
Ifomula yemolekyuli: c18h12o3
Ubunzima bemolekyuli: 276.286
Indawo edanyazayo: 245.9 ± 15.6 ° C
Ubunzima obuchanekileyo: 276.078644
PSA:47.28000
IlogP:4.44
Uxinzelelo lomphunga: 0.0 ± 1.3 mmHg ku-25 ° C
Isalathiso se-refractive: 1.676
Iimeko zokugcina: 2-8 ° C
Ulwazi lokhuseleko lweTanshinone I
Ingxelo yobungozi: h413
Ikhowudi yezothutho yempahla eyingozi: nonh kuzo zonke iindlela zothutho
Uncwadi
Ukumodareyithwa kwe-esterified drug metabolism yi-tanshinones esuka kwiSalvia miltiorrhiza ("Danshen").
J. Nat.Imveliso.76(1), 36-44, (2013)
Iingcambu zeSalvia miltiorrhiza ("Danshen") zisetyenziselwa amayeza emveli aseTshayina kunyango lwezifo ezininzi ezibandakanya isifo sentliziyo, uxinzelelo lwegazi, kunye ne-ischemic stroke.Eyongezelelweyo...
I-Tanshinone IIA inqanda ukubonakaliswa kwentsholongwane ye-oncogene ekhokelela kwi-apoptosis kunye nokuthintelwa komhlaza womlomo wesibeleko.
Umhlaza Lett.356(2 Pt B), 536-46, (2015)
Intsholongwane ye-Human papilloma virus (HPV) yeyona nto isekwe kakuhle ye-etiological factor yomhlaza womlomo wesibeleko.I-E6 kunye ne-E7 i-oncoproteins echazwe yi-HPV ziyaziwa ukuba zingasebenzi iiprotheni ze-tumor suppressor p53 kunye ne-pRb, i-respec ...
I-Cloning, i-molecular characterization kunye nohlalutyo olusebenzayo lwe-1-hydroxy-2-methyl-2- (E) -butenyl-4-diphosphate reductase (HDR) gene ye-diterpenoid tanshinone biosynthesis kwi-Salvia miltiorrhiza Bge.f.alba.
IPhysiol yezityalo.Biochem.70 , 21-32, (2013)
I-enzyme ye-1-hydroxy-2-methyl-2- (E) -butenyl-4-diphosphate reductase (HDR) yi-enzyme ye-terminal-acting kwindlela ye-plastid ye-MEP, evelisa i-isoprenoid precursors.Ubude obugcweleyo be-cDNA ye-HDR, desi...
Uncwadi lweCycloastragalol
I-Cycloastragenol yinto enamandla ye-telomerase activator kwiiseli ze-neuronal: iimpembelelo kulawulo lokudakumba.
Ii-Neurosignals 22(1) , 52-63, (2014)
I-Cycloastragenol (CAG) yi-aglycone ye-astragaloside IV.Yaqala ukuchongwa xa kuhlolwa i-Astragalus membranaceus extracts yezithako ezisebenzayo ezineempawu zokuguga.Uphononongo lwangoku ...
Inoveli ye-telomerase activator icinezela umonakalo wemiphunga kwimodeli ye-murine ye-idiopathic pulmonary fibrosis.
PLoS ONE 8(3) , e58423, (2013)
Ukuvela kwezifo ezinxulumene nokungasebenzi kakuhle kwe-telomere, kubandakanya i-AIDS, i-aplastic anemia kunye ne-pulmonary fibrosis, kuye kwaqinisa umdla kwi-activators ye-telomerase.Sinika ingxelo ngokuchongwa kwen...
I-Telomerase-based pharmacologic yokuphucula umsebenzi we-antiviral we-CD8+ T lymphocytes yabantu.
J. Immunol.181(10), 7400-6, (2008)
I-Telomerase ibuyisela umva ikhuphela i-telomere DNA kwiziphelo zechromosomes kwaye ibambezela ukuguga kweeseli.Ngokwahlukileyo kwiiseli ezininzi eziqhelekileyo ze-somatic, ezibonisa umsebenzi omncinci okanye ongekhoyo we-telomerase, i-immun ...
Igama lesiNgesi likaTanshinone I
ISalvia quinone
Phenanthrop[1,2-b]furan-10,11-dione, 1,6-dimethyl-
Tanshinone
Tanshinon I
tanshinone-I
Tanshinone 1
I-1,6-Dimethylphenanthrop[1,2-b]furan-10,11-dione
TANSHINONES IIA
Tanshiquinone I
MFCD00238692